EMA Accepts EISAI´S License Extension Application for Zonegran (zonisamide) in Epilepsy (28. Juli 2011, 01:01 Uhr)
Links shared publicly online about this topic.
- 115total visits
EMA Accepts EISAI´S License Extension Application for Zonegran (zonisamide) in Epilepsy (28. Juli 2011, 01:01 Uhr)
HATFIELD, England, July 28, 2011 /PRNewswire/ Eisai today announced that the European Medicines Agency (EMA) has accepted for review their application to extend the use of Zonegran (zonisamide) as monotherapy for newly diagnosed epilepsy ...
View full resource at wallstreet-online.de
Tags: Seizure, Epilepsy, Eisai, Medical, Medicine
Most Recently Shared on July 28, 2011 at 1:38 am By:
EMA Accepts EISAI´S License Extension Application for Zonegran (zonisamide) in Epilepsy: HATFIELD, England, July... http://bit.ly/o7sNqB
Advertisement
